{"name":"ForSight Vision5, Inc.","slug":"forsight-vision5-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"VISION5 Product","genericName":"VISION5 Product","slug":"vision5-product","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"VISION5 Product","genericName":"VISION5 Product","slug":"vision5-product","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPMjctYmpoLTdoZG5Zc3BoV0w3YVZfS2pwN0lOOWNnR0ZZTzV5ekJRaGdKYVdpZXhNQ3RZb05QVG9rU3NNRXl0WEY4YWF6TU5mQmctQ3llazZOTElrN0RGZDZhT1lpVWtLRUttVmxPM1FJR3ViOG52ajVSZTBwZ3RFcV9WUUFXOEJ1QXliTnllbGxHOEE?oc=5","date":"2024-06-21","type":"pipeline","source":"SEC.gov","summary":"abbv-20221231xex21.htm - SEC.gov","headline":"abbv-20221231xex21.htm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOZk0yYUVvMnh3TXFOUS1EWTlZbHE2bGNkVVoyMWEyQUdSNnYtUnFRVmpjNEczVWNSMk5heGpGOHBXT1U4WE5ONW0wNXpUeHFmUnRVTzl5R0Jra0Ztb3lLVE1zcUdHOWVkc1d4eWRwc3ZTNy1tSndnSC13VHlocndmdEZLTXJxM3lCTlBnWTducmwtVmo2eEpxbFpHVU5nb0VQc1RueHJNUHY5aGRET0RvdTV3MA?oc=5","date":"2022-01-25","type":"pipeline","source":"businesswire.com","summary":"Lisa Garrett Joins Channel Medsystems Board of Directors - businesswire.com","headline":"Lisa Garrett Joins Channel Medsystems Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNVkpjekJMMEo5TnNwa1NSMEU3cFd1dzZna0ZoczZ4UzNReTA0dEx0TEN6V1VsWHVIdEY2cnpwYk5hQ2lKQzFIa05GeUwzXzl5TVZOc2NBbm5PdXluNW9Pb0JoOTM4dW91NlNCREd3Z25mTWZWZnlsV0RIMWppQUxpbHBMSTZ4d0UzVlBxT3RXeDIydzU2RVRTRW9hTHJTWXVlQkM2N3hKUDBpdw?oc=5","date":"2016-10-03","type":"pipeline","source":"Fierce Pharma","summary":"Bayer signs up DelSiTech ophthalmology drug delivery technology - Fierce Pharma","headline":"Bayer signs up DelSiTech ophthalmology drug delivery technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOaXdjUkVEZGU5TFJRckM0cUN2UkVpQWt2eW5sSlU1YlhKRFZjdmRxTlhoZnZWR1lzMWIyYTVrM2ZJSnduR3hmYUE2RDFGQ1FncHJGSVRIWnFreFVtZWl2T2g0V0I1Z0MyQW9rbm9tSnNUeGJQVVdkWnJZdjJFb1dzNTVFaHZMSkxMN1U4b25ZeXpZRWg0ZmloX04xSWo?oc=5","date":"2016-09-20","type":"pipeline","source":"BioPharma Dive","summary":"Allergan pays steep premium for Tobira and NASH drugs - BioPharma Dive","headline":"Allergan pays steep premium for Tobira and NASH drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNc3NEWEtnZEV0SFRvSGgxbnZYWG1lLXc2QXBvMHBfdV9wLUVRQWR5RHVCdGctVEJMZW9JQlV1Q0lVTmpNVnRKRWVWczUwdlhTbGZpZ29vdzctTVFPUTVIZkQ0cXdJYUdnODZSUkNEM3pBSi02RTJfdmUxWFdPcW92UXFuOXpvOU1ucms0?oc=5","date":"2016-09-06","type":"pipeline","source":"BioPharma Dive","summary":"Allergan picks up gene therapy company - BioPharma Dive","headline":"Allergan picks up gene therapy company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxPNTZCeDNRSkJxdncxcnI1M3VUdzR6TWl1M2JvSTJ5QklRWmpSN1VhTE91NGp3MXpNV2N2T2hnRUZtVVRtT0dGMHhiRnA5QmdTeE9kdlRTa2RRVjdUZUlsOTh5aVNUeE5mUGc3YVpuenJHSTlIZVEzMGdqVUc5VVYxSjdJTDZOMnBzbHM0VUlpRzd5cDRJRDhVOWhUZ2hKcVJjclU1Z0YzMW04VkhBal92dzd2X3BQVVdiS09aV3VLaDY1UWtabU94d0xlNkRsbU92bDJ1QWp3RTRaZUxBSG9ycW95N3B6UE5PUlN1ZTJFNHdWU2J5c3pFX2pubUprbDdHejBJX3FJNTZzLThtUXBZa3JEc2ZCNmhPcm1LbExoVUVlNThmdUVOdHBVVTRaTVBKUEE?oc=5","date":"2016-08-11","type":"deal","source":"PR Newswire","summary":"Allergan to Acquire Eye Care Company ForSight VISION5 Adding Peri-Ocular Ring Technology to Company's Leading Portfolio of Innovative Eye Health Products - PR Newswire","headline":"Allergan to Acquire Eye Care Company ForSight VISION5 Adding Peri-Ocular Ring Technology to Company's Leading Portfolio ","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2016-01-12","type":"pipeline","source":"Newswise","summary":"Glaucoma Research Foundation to Host Fifth Annual Glaucoma 360 New Horizons Forum | Newswise - Newswise","headline":"Glaucoma Research Foundation to Host Fifth Annual Glaucoma 360 New Horizons Forum | Newswise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQZTZfSEtEODdnd05vc3pNc3F0V2N5SVAtRjhjNWFUOXBva09IWGQ3R1FrTU9nOXFkT2d4bGRxYjhNZEVHOGsyTWJ6R2RKSUMxVENDLWFTdW5TWHFra1BGSllaRW5nSjIxNXNNUVEyLTlYWWozQnRnR3lyX1I5OWt1YkhOeHRyM3VJS2tfSnUwcW0zVXpHTUZRdFV5Yw?oc=5","date":"2015-07-07","type":"pipeline","source":"Med Device Online","summary":"Allergan Snaps Up Early-Stage Device Developer Oculeve - Med Device Online","headline":"Allergan Snaps Up Early-Stage Device Developer Oculeve","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}